Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Acoustic Neuroma Market

ID: MRFR/MED/17442-HCR
100 Pages
Satyendra Maurya
Last Updated: April 06, 2026

US Acoustic Neuroma Market Research Report By Type (unilateral vestibular schwannomas, bilateral vestibular schwannomas), By Diagnosis (hearing test (audiometry), electronystagmography, magnetic resonance imaging (MRI), others), By Drug Class (anticonvulsants, corticosteroids, osmotic diuretics, pain killers), By Treatment (monitoring, surgery, radiation therapy, supportive therapy, others, stereotactic radiotherapy, proton beam therapy, radiosurgery, craniotomy, microsurgery removal) and By End User (hospitals, diagnostic centers, academic and research institutes, others) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Acoustic Neuroma Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Medical Device, BY Type (USD Million)
  49.     4.1.1 Unilateral Vestibular Schwannomas
  50.     4.1.2 Bilateral Vestibular Schwannomas
  51.   4.2 Medical Device, BY Diagnosis (USD Million)
  52.     4.2.1 Hearing Test (Audiometry)
  53.     4.2.2 Electronystagmography
  54.     4.2.3 Magnetic Resonance Imaging (MRI)
  55.     4.2.4 Others
  56.   4.3 Medical Device, BY Drug Class (USD Million)
  57.     4.3.1 Anticonvulsants
  58.     4.3.2 Corticosteroids
  59.     4.3.3 Osmotic Diuretics
  60.     4.3.4 Pain Killers
  61.   4.4 Medical Device, BY Treatment (USD Million)
  62.     4.4.1 Monitoring
  63.     4.4.2 Surgery
  64.     4.4.3 Radiation Therapy
  65.     4.4.4 Supportive Therapy
  66.     4.4.5 Others
  67.   4.5 Medical Device, BY End-User (USD Million)
  68.     4.5.1 Hospitals
  69.     4.5.2 Diagnostic Centers
  70.     4.5.3 Academic and Research Institutes
  71.     4.5.4 Others
  72. 5 SECTION V: COMPETITIVE ANALYSIS
  73.   5.1 Competitive Landscape
  74.     5.1.1 Overview
  75.     5.1.2 Competitive Analysis
  76.     5.1.3 Market share Analysis
  77.     5.1.4 Major Growth Strategy in the Medical Device
  78.     5.1.5 Competitive Benchmarking
  79.     5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  80.     5.1.7 Key developments and growth strategies
  81.       5.1.7.1 New Product Launch/Service Deployment
  82.       5.1.7.2 Merger & Acquisitions
  83.       5.1.7.3 Joint Ventures
  84.     5.1.8 Major Players Financial Matrix
  85.       5.1.8.1 Sales and Operating Income
  86.       5.1.8.2 Major Players R&D Expenditure. 2023
  87.   5.2 Company Profiles
  88.     5.2.1 Medtronic (US)
  89.       5.2.1.1 Financial Overview
  90.       5.2.1.2 Products Offered
  91.       5.2.1.3 Key Developments
  92.       5.2.1.4 SWOT Analysis
  93.       5.2.1.5 Key Strategies
  94.     5.2.2 Stryker (US)
  95.       5.2.2.1 Financial Overview
  96.       5.2.2.2 Products Offered
  97.       5.2.2.3 Key Developments
  98.       5.2.2.4 SWOT Analysis
  99.       5.2.2.5 Key Strategies
  100.     5.2.3 Johnson & Johnson (US)
  101.       5.2.3.1 Financial Overview
  102.       5.2.3.2 Products Offered
  103.       5.2.3.3 Key Developments
  104.       5.2.3.4 SWOT Analysis
  105.       5.2.3.5 Key Strategies
  106.     5.2.4 Boston Scientific (US)
  107.       5.2.4.1 Financial Overview
  108.       5.2.4.2 Products Offered
  109.       5.2.4.3 Key Developments
  110.       5.2.4.4 SWOT Analysis
  111.       5.2.4.5 Key Strategies
  112.     5.2.5 Cochlear (AU)
  113.       5.2.5.1 Financial Overview
  114.       5.2.5.2 Products Offered
  115.       5.2.5.3 Key Developments
  116.       5.2.5.4 SWOT Analysis
  117.       5.2.5.5 Key Strategies
  118.     5.2.6 Siemens Healthineers (DE)
  119.       5.2.6.1 Financial Overview
  120.       5.2.6.2 Products Offered
  121.       5.2.6.3 Key Developments
  122.       5.2.6.4 SWOT Analysis
  123.       5.2.6.5 Key Strategies
  124.     5.2.7 Abbott Laboratories (US)
  125.       5.2.7.1 Financial Overview
  126.       5.2.7.2 Products Offered
  127.       5.2.7.3 Key Developments
  128.       5.2.7.4 SWOT Analysis
  129.       5.2.7.5 Key Strategies
  130.     5.2.8 NeuroPace (US)
  131.       5.2.8.1 Financial Overview
  132.       5.2.8.2 Products Offered
  133.       5.2.8.3 Key Developments
  134.       5.2.8.4 SWOT Analysis
  135.       5.2.8.5 Key Strategies
  136.   5.3 Appendix
  137.     5.3.1 References
  138.     5.3.2 Related Reports
  139. 6 LIST OF FIGURES
  140.   6.1 MARKET SYNOPSIS
  141.   6.2 US MARKET ANALYSIS BY TYPE
  142.   6.3 US MARKET ANALYSIS BY DIAGNOSIS
  143.   6.4 US MARKET ANALYSIS BY DRUG CLASS
  144.   6.5 US MARKET ANALYSIS BY TREATMENT
  145.   6.6 US MARKET ANALYSIS BY END-USER
  146.   6.7 KEY BUYING CRITERIA OF MEDICAL DEVICE
  147.   6.8 RESEARCH PROCESS OF MRFR
  148.   6.9 DRO ANALYSIS OF MEDICAL DEVICE
  149.   6.10 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
  150.   6.11 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
  151.   6.12 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
  152.   6.13 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE)
  153.   6.14 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Million)
  154.   6.15 MEDICAL DEVICE, BY DIAGNOSIS, 2024 (% SHARE)
  155.   6.16 MEDICAL DEVICE, BY DIAGNOSIS, 2024 TO 2035 (USD Million)
  156.   6.17 MEDICAL DEVICE, BY DRUG CLASS, 2024 (% SHARE)
  157.   6.18 MEDICAL DEVICE, BY DRUG CLASS, 2024 TO 2035 (USD Million)
  158.   6.19 MEDICAL DEVICE, BY TREATMENT, 2024 (% SHARE)
  159.   6.20 MEDICAL DEVICE, BY TREATMENT, 2024 TO 2035 (USD Million)
  160.   6.21 MEDICAL DEVICE, BY END-USER, 2024 (% SHARE)
  161.   6.22 MEDICAL DEVICE, BY END-USER, 2024 TO 2035 (USD Million)
  162.   6.23 BENCHMARKING OF MAJOR COMPETITORS
  163. 7 LIST OF TABLES
  164.   7.1 LIST OF ASSUMPTIONS
  165.     7.1.1
  166.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  167.     7.2.1 BY TYPE, 2025-2035 (USD Million)
  168.     7.2.2 BY DIAGNOSIS, 2025-2035 (USD Million)
  169.     7.2.3 BY DRUG CLASS, 2025-2035 (USD Million)
  170.     7.2.4 BY TREATMENT, 2025-2035 (USD Million)
  171.     7.2.5 BY END-USER, 2025-2035 (USD Million)
  172.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  173.     7.3.1
  174.   7.4 ACQUISITION/PARTNERSHIP
  175.     7.4.1

US Medical Device Market Segmentation

Medical Device By Type (USD Million, 2025-2035)

  • Unilateral Vestibular Schwannomas
  • Bilateral Vestibular Schwannomas

Medical Device By Diagnosis (USD Million, 2025-2035)

  • Hearing Test (Audiometry)
  • Electronystagmography
  • Magnetic Resonance Imaging (MRI)
  • Others

Medical Device By Drug Class (USD Million, 2025-2035)

  • Anticonvulsants
  • Corticosteroids
  • Osmotic Diuretics
  • Pain Killers

Medical Device By Treatment (USD Million, 2025-2035)

  • Monitoring
  • Surgery
  • Radiation Therapy
  • Supportive Therapy
  • Others

Medical Device By End-User (USD Million, 2025-2035)

  • Hospitals
  • Diagnostic Centers
  • Academic and Research Institutes
  • Others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓